A breast cancer diagnosis can be jarring, and millions of women receive such news across the globe each year.
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference ...
Researchers evaluate whether negative margins < 2 mm are linked to higher ipsilateral recurrence risk than margins ≥ 2 mm after breast-conserving surgery for ductal carcinoma in situ.
As Breast Cancer Awareness Month kicks off, the news reporter, who was diagnosed with early-stage cancer at age 32, is ...
Not everyone has the same risk of developing breast cancer, and some women can benefit from additional screening, like Joni ...
When the World Health Organization declared Covid-19 a pandemic in March 2020, South Africa responded with one of the world’s longest national lockdowns, stretching from March 2020 to June 2022. H ...
The surgical management of breast cancer in patients with coronary artery disease presents significant challenges, requiring a balance between oncological treatment and cardiovascular stability. A ...
Ductal carcinoma in situ (DCIS) constitutes a non-invasive precursor to breast cancer in which malignant cells remain confined to the ductal system. Its detection has risen sharply with widespread ...
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE) Tamoxifen 20 mg once-daily reduces the risk of breast cancer recurrence after ductal carcinoma in ...
When you’re diagnosed with breast cancer, one of your first concerns is likely whether it’s spread. To answer questions like this, your doctor must determine the stage. Physicians use staging to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results